eISSN 2039-4365
 
Editor-in-Chief
Aurelio Maggio
Palermo, Italy
 
thalassemia
What is thalassemia?
 
ADVERTISING
Advertising
 

Thalassemia Reports is the premier peer-reviewed international medical journal devoted entirely to the study, diagnosis, and treatment of thalassemia. The journal covers the pathophysiology, diagnosis, classification, and treatment of thalassemia and related disorders for physicians and medical scientists. The primary intent of the journal will be to publish clinically relevant information that will directly improve the care of patients with thalassemia. Basic science studies of interest to those treating disorders will also be considered for publication when relevant. A special section of the journal is dedicated to Case Reports: we would like to invite clinicians and researchers to send us their reports.

Announcements

Covid19 in Thalassemia patients

2020-05-04

The Piera Cutino Association (Associazione Piera Cutino) - committed for over twenty years in the fight against hemoglobinopathies - on the occasion of the Thalassemia Day, which will take place next May 8th, asked several medical representatives of the Thalassemia Centres in Italy and elsewhere, to send a video interview in which they talk about the incidence of the COVID-19 pandemic in their country and in particular in their Thalassemia Centre.

Objectives:

  • To understand if there has been a significant correlation of cases of infected people among patients;
  • To understand how patients reacted to the pandemic;
  • To verify if there were any particular problems related to COVID-19 in the management of the usual treatment of the patient

A first important overview of general interest with Thalassaemia and COVID-19 topics that we believe can be very useful. All videos will be published at: www.pieracutino.it.

SLIDE: Covid19.AK.pptx
VIDEO: DrSumanJain Talk Covid19
VIDEO ZIP: Thal and Covid19 Greece kattamis
THE COVID–19 PANDEMIC AND HAEMOGLOBIN DISORDERS - VACCINATIONS & THERAPEUTIC DRUGS
THE COVID–19 PANDEMIC AND HAEMOGLOBIN DISORDERS - VACCINATIONS & THERAPEUTIC DRUGS – WEEKLY UPDATES
THE COVID–19 PANDEMIC AND HAEMOGLOBIN DISORDERS - BLOOD
THE COVID–19 PANDEMIC AND HAEMOGLOBIN DISORDERS - Thalassaemia & Sickle Cell Disease: Classification of Risk Groups & Other Considerations

Dr. Sergio Mangano,
Communication, Marketing and Fundraising Director

Read more about Covid19 in Thalassemia patients